{"name": "Questcor Pharmaceuticals",
 "permalink": "questcor-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/questcor-pharmaceuticals",
 "homepage_url": "http://questcor.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "714.786.4200",
 "description": "",
 "created_at": "Wed Jun 12 05:54:59 UTC 2013",
 "updated_at": "Wed Jun 12 06:01:56 UTC 2013",
 "overview": "\u003Cp\u003EQuestcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Our specific areas of focus are in the fields of neurology and nephrology and we are currently supporting research efforts in a variety of conditions having significant unmet medical need. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       24],
      "assets/images/resized/0027/4253/274253v1-max-150x150.png"],
     [[250,
       40],
      "assets/images/resized/0027/4253/274253v1-max-250x250.png"],
     [[280,
       45],
      "assets/images/resized/0027/4253/274253v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Don",
      "last_name": "M. Bailey",
      "permalink": "don-m-bailey",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1300 North Kellogg Drive",
    "address2": "Suite D",
    "zip_code": "92807",
    "city": "Anaheim Hills",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Acquires Rights to Synacthen From Novartis AG (NVS) for Up $135 Million",
    "stoned_year": 2013,
    "stoned_month": 6,
    "stoned_day": 11,
    "source_url": "http://www.biospace.com/news_story.aspx?StoryID=299627\u0026full=1",
    "source_text": "",
    "source_description": "Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Acquires Rights to Synacthen From Novartis AG (NVS) for Up $135 Million",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Questcor Pharmaceuticals",
      "permalink": "questcor-pharmaceuticals"}}],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:QCOR"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0027/4252/274252v1-max-150x150.png"],
      [[250,
        134],
       "assets/images/resized/0027/4252/274252v1-max-250x250.png"],
      [[450,
        242],
       "assets/images/resized/0027/4252/274252v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}